These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 15808248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.
    Krämer F, White K, Pauleikhoff D, Gehrig A, Passmore L, Rivera A, Rudolph G, Kellner U, Andrassi M, Lorenz B, Rohrschneider K, Blankenagel A, Jurklies B, Schilling H, Schütt F, Holz FG, Weber BH.
    Eur J Hum Genet; 2000 Apr; 8(4):286-92. PubMed ID: 10854112
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
    Armstrong JD, Meyer D, Xu S, Elfervig JL.
    Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
    [Abstract] [Full Text] [Related]

  • 7. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
    Boon CJ, van den Born LI, Visser L, Keunen JE, Bergen AA, Booij JC, Riemslag FC, Florijn RJ, van Schooneveld MJ.
    Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
    [Abstract] [Full Text] [Related]

  • 8. Morphology and functional characteristics in adult vitelliform macular dystrophy.
    Renner AB, Tillack H, Kraus H, Kohl S, Wissinger B, Mohr N, Weber BH, Kellner U, Foerster MH.
    Retina; 2004 Dec; 24(6):929-39. PubMed ID: 15579992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
    Khurana RN, Sun X, Pearson E, Yang Z, Harmon J, Goldberg MF, Zhang K.
    Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Retinal function in best macular dystrophy: relationship between electrophysiological, psychophysical, and structural measures of damage.
    Maia-Lopes S, Silva ED, Reis A, Silva MF, Mateus C, Castelo-Branco M.
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5553-60. PubMed ID: 18775865
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene.
    Eksandh L, Bakall B, Bauer B, Wadelius C, Andréasson S.
    Ophthalmic Genet; 2001 Jun; 22(2):107-15. PubMed ID: 11449320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of 14 japanese patients with X-linked juvenile retinoschisis associated with XLRS1 mutation.
    Shinoda K, Ishida S, Oguchi Y, Mashima Y.
    Ophthalmic Genet; 2000 Sep; 21(3):171-80. PubMed ID: 11035549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.